Showing results (681-690 of 3,978) with videos related to
Sort By:
Pageof 398
European Journal of Heart Failure|September 19, 2020
Cachexia, muscle wasting, and frailty in cardiovascular diseaseAgata Bielecka-Dabrowa, Nicole Ebner, Marcelo Rodrigues Dos Santos, et al.European Journal of Heart Failure|April 1, 2020
Readmission and death in patients admitted with new-onset versus worsening of chronic heart failure: insights from a nationwide cohortJawad H Butt, Emil L Fosbøl, Thomas A Gerds, et al.European Journal of Heart Failure|September 28, 2020
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trialsJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.European Journal of Heart Failure|December 28, 2020
Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA-HFPooja Dewan, Kieran F Docherty, Olof Bengtsson, et al.European Journal of Heart Failure|December 21, 2020
Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double-blind, randomized, placebo-controlled clinical trialMark R Hazebroek, Michiel T H M Henkens, Anne G Raafs, et al.European Journal of Heart Failure|June 11, 2021
Influence of study discontinuation during the run-in period on the estimated efficacy of sacubitril/valsartan in the PARAGON-HF trialKota Suzuki, Brian Claggett, Masatoshi Minamisawa, et al.European Journal of Heart Failure|June 11, 2021
Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsyNicolas L Palaskas, Ana Segura, Laura Lelenwa, et al.European Journal of Heart Failure|June 18, 2021
Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo-controlled, non-inferiority ARIES HM3 trialMandeep R Mehra, Daniel L Crandall, Finn Gustafsson, et al.European Journal of Heart Failure|July 9, 2021
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative reviewJulio Núñez, Rafael de la Espriella, Gema Miñana, et al.European Journal of Heart Failure|October 16, 2020
Telemonitoring in patients with chronic heart failure and moderate depressed symptoms: results of the Telemedical Interventional Monitoring in Heart Failure (TIM-HF) studyJohanna Koehler, Andreas Stengel, Tobias Hofmann, et al.Pageof 398